Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaern

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Human papilloma virus has no prognostic significance in cervical carcinomaG B Kristensen, F Karlsen, A Jenkins, et al.
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Gynecologic Oncology|May 1, 1996
Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatmentM Scheistrøen, C Tropé, J Kaern, et al.
Gynecologic Oncology|April 1, 1995
No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patientsG B Kristensen, J Kaern, V M Abeler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?J Kaern, M Aghmesheh, J M Nesland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Molecular and biological factors in the pathogenesis of ovarian cancerJ S Berek, O Martínez-Maza, T Hamilton, et al.
Gynecologic Oncology|August 1, 1996
The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcomaR R Nordal, G B Kristensen, J Kaern, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcomaR R Nordal, G B Kristensen, J Kaern, et al.
Obstetrics and Gynecology|June 1, 1992
Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysisA P Makar, G B Kristensen, J Kaern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancerG B Kristensen, W Kildal, V M Abeler, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Human papilloma virus has no prognostic significance in cervical carcinomaG B Kristensen, F Karlsen, A Jenkins, et al.
British Journal of Cancer|August 14, 1998
Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene statusB Smith-Sørensen, J Kaern, R Holm, et al.
Gynecologic Oncology|May 1, 1996
Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatmentM Scheistrøen, C Tropé, J Kaern, et al.
Gynecologic Oncology|April 1, 1995
No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patientsG B Kristensen, J Kaern, V M Abeler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 14, 2005
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?J Kaern, M Aghmesheh, J M Nesland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Molecular and biological factors in the pathogenesis of ovarian cancerJ S Berek, O Martínez-Maza, T Hamilton, et al.
Gynecologic Oncology|August 1, 1996
The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcomaR R Nordal, G B Kristensen, J Kaern, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcomaR R Nordal, G B Kristensen, J Kaern, et al.
Obstetrics and Gynecology|June 1, 1992
Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysisA P Makar, G B Kristensen, J Kaern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancerG B Kristensen, W Kildal, V M Abeler, et al.
Pageof 7